Chairs: Prasad Iyer (USA) – Marcia (Mimi) Canto (USA)

1. How should patients with established Barrett’s esophagus be followed? – Kerry Dunbar (USA)
2. Is long-term surveillance necessary for low-risk patients? – Oliver Old (UK)
3. Should all patients with dysplasia undergo ablation? – Allon Kahn (USA)
4. How should Barrett’s esophagus with nodularity be treated? – Massimiliano Di Pietro (UK)
5. How should patients be followed after endoscopic ablation? – Michael Smith (USA)
6. Will artificial intelligence change the management of Barrett’s esophagus? – Don C. Codipilly (USA)